EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Neural substrates underlying distinct dual cognitive syndromes in Parkinson's disease

Kenji Yoshimura iD, Atsushi Shima iD, Daisuke Kambe, Koji Furukawa, Akira Nishida, Ikko Wada, Yusuke Sakato, Haruhi Sakamaki-Tsukita, Yuta Terada, Hodaka Yamakado, Yosuke Taruno, Etsuro Nakanishi und 8 weitere

European Journal of Neurology · 2025-01 · 32 (1)

DOI: 10.1111/ene.70022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 24.12.2024. Verfasst von Kenji Yoshimura und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Parkinson Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A dual‐syndrome hypothesis, which states the cognitive impairments in Parkinson's disease (PD) are attributable to frontostriatal dopaminergic dysregulation and cortical disturbance—each associated with attention/executive and memory/visuospatial dysfunction, respectively—has been widely accepted. This multisystem contribution also underlies highly heterogeneous progression rate to dementia.

Methods

Nondemented PD patients who underwent [ 123 I]N‐ω‐fluoropropyl‐2β‐carbomethoxy‐3β‐(4‐iodophenyl) nortropane ([ 123 I]FP‐CIT) SPECT and neuropsychological examinations were enrolled. Patients who agreed to participate and age‐ and sex‐matched healthy controls (HCs) also underwent 7‐T MRI. Patients were classified as cognitively normal (PD‐CN) or mild cognitive impairment (PD‐MCI) following the level II criteria of Movement Disorder Society Guideline.

Results

A total of 155 patients (PD‐CN/PD‐MCI 74/81) were enrolled, whereas 76 patients (PD‐CN/PD‐MCI 35/41) and 56 HCs underwent 7 T‐MRI. The caudate [ 123 I]FP‐CIT uptake in PD was correlated with the performance of attention/working memory (trail‐making test [TMT]‐A and symbol digit modality test) and executive (TMT‐B) domains. In contrast, the regional cortical thickness in the left frontotemporal and right frontal lobes in PD was correlated with performance of memory (Hopkins verbal learning test‐revised delayed recall) and visuospatial (judgment of line orientation) domains. Moreover, compared to 37 HCs with a Montreal Cognitive Assessment score of >25, PD‐CN patients showed broad occipitoparietal cortical thinning.

Conclusions

We demonstrated distinctive impairments of dopaminergic frontostriatal deficits and cortical degeneration as neural bases for the dual‐syndrome hypothesis. Our findings suggest that occipitoparietal lobe thinning occurs at a cognitively normal stage, and additional frontotemporal lobe thinning underlies impairments in the memory and visuospatial domains at the PD‐MCI stage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseCognitive DysfunctionHumansMaleFemaleAgedMiddle AgedMagnetic Resonance ImagingTomography, Emission-Computed, Single-PhotonTropanesNeuropsychological TestsExecutive Function

Stichwörter der Autor:innen

7 T‐MRIParkinson's disease[123I]FP‐CIT SPECTmild cognitive impairmentsurface‐based morphometry

Substanzen

Tropanes2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

Autor:innen und Institutionen

  • Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Human Brain Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.

ORCID-Profile: Kenji Yoshimura, Atsushi Shima, Nobukatsu Sawamoto

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Japan Science and Technology Agency

Zitieren

APA

Yoshimura, K., Shima, A., Kambe, D., Furukawa, K., Nishida, A., Wada, I., Sakato, Y., Sakamaki-Tsukita, H., Terada, Y., Yamakado, H., Taruno, Y., Nakanishi, E., Sawamura, M., Fujimoto, K., Fushimi, Y., Okada, T., Nakamoto, Y., Hanakawa, T., Takahashi, R., & Sawamoto, N. (2025). Neural substrates underlying distinct dual cognitive syndromes in Parkinson's disease. European Journal of Neurology, 32(1). https://doi.org/10.1111/ene.70022

Vancouver

Yoshimura K, Shima A, Kambe D, Furukawa K, Nishida A, Wada I, et al. Neural substrates underlying distinct dual cognitive syndromes in Parkinson's disease. European Journal of Neurology. 2025;32(1). doi:10.1111/ene.70022

BibTeX
@article{Yoshimura2025,
  author = {Yoshimura, Kenji and Shima, Atsushi and Kambe, Daisuke and Furukawa, Koji and Nishida, Akira and Wada, Ikko and Sakato, Yusuke and Sakamaki-Tsukita, Haruhi and Terada, Yuta and Yamakado, Hodaka and Taruno, Yosuke and Nakanishi, Etsuro and Sawamura, Masanori and Fujimoto, Koji and Fushimi, Yasutaka and Okada, Tomohisa and Nakamoto, Yuji and Hanakawa, Takashi and Takahashi, Ryosuke and Sawamoto, Nobukatsu},
  title = {Neural substrates underlying distinct dual cognitive syndromes in Parkinson's disease},
  journal = {European Journal of Neurology},
  year = {2025},
  volume = {32},
  number = {1},
  doi = {10.1111/ene.70022}
}
Kostenlos starten →